$BTM
Bitcoin Depot Inc.

2023 Q1 Form 10-Q Financial Statement

#000119312523136197 Filed on May 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $139.1M $138.0M
YoY Change 0.8%
Gross Profit $24.50M $16.50M
YoY Change 48.48%
Gross Profit Margin
Selling, General & Admin $2.125M $212.5K
YoY Change 900.38%
% of Gross Profit 8.67% 1.29%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.800M $4.800M
YoY Change -41.67%
% of Gross Profit 11.43% 29.09%
Operating Expenses $2.125M $212.5K
YoY Change 900.38%
Operating Profit -$2.125M -$212.5K
YoY Change 900.38%
Interest Expense $3.089M -$226.8K
YoY Change -1462.41%
% of Operating Profit
Other Income/Expense, Net $3.089M -$226.8K
YoY Change -1462.41%
Pretax Income $964.1K -$439.2K
YoY Change -319.51%
Income Tax $638.3K $0.00
% Of Pretax Income 66.2%
Net Earnings $325.8K -$439.2K
YoY Change -174.18%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.01 -$11.11K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $75.35K $1.759M
YoY Change -95.72%
Cash & Equivalents $75.00K $1.759M
Short-Term Investments
Other Short-Term Assets $452.6K $923.0K
YoY Change -50.96%
Inventory
Prepaid Expenses $452.6K
Receivables $750.0K
Other Receivables $0.00
Total Short-Term Assets $528.0K $2.682M
YoY Change -80.32%
LONG-TERM ASSETS
Property, Plant & Equipment $35.66M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $328.3M $320.8M
YoY Change 2.36%
Other Assets $20.00K
YoY Change
Total Long-Term Assets $328.3M $320.8M
YoY Change 2.36%
TOTAL ASSETS
Total Short-Term Assets $528.0K $2.682M
Total Long-Term Assets $328.3M $320.8M
Total Assets $328.9M $323.4M
YoY Change 1.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $254.7K $8.220K
YoY Change 2998.59%
Accrued Expenses $4.661M $120.1K
YoY Change 3782.62%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $24.54M
YoY Change
Total Short-Term Liabilities $6.495M $128.3K
YoY Change 4963.41%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $210.0K
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.495M $128.3K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $6.495M $128.3K
YoY Change 4963.41%
SHAREHOLDERS EQUITY
Retained Earnings -$4.289M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.288M $2.327M
YoY Change
Total Liabilities & Shareholders Equity $328.9M $323.4M
YoY Change 1.67%

Cashflow Statement

Concept 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $325.8K -$439.2K
YoY Change -174.18%
Depreciation, Depletion And Amortization $2.800M $4.800M
YoY Change -41.67%
Cash From Operating Activities -$601.9K -$1.088M
YoY Change -44.68%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $370.0K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $200.1K -$321.0M
YoY Change -100.06%
Cash From Investing Activities $200.1K -$321.0M
YoY Change -100.06%
FINANCING ACTIVITIES
Cash Dividend Paid $482.0K
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 323.8M
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -601.9K -1.088M
Cash From Investing Activities 200.1K -321.0M
Cash From Financing Activities 0.000 323.8M
Net Change In Cash -401.8K 1.715M
YoY Change -123.44%
FREE CASH FLOW
Cash From Operating Activities -$601.9K -$1.088M
Capital Expenditures $0.00 $370.0K
Free Cash Flow -$601.9K -$1.458M
YoY Change -58.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei City Area Code
CityAreaCode
561
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
532-4682
CY2023Q1 dei Security12b Title
Security12bTitle
Class A common stock, par value $0.0001 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
GSRM
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
true
CY2023Q1 us-gaap Cash
Cash
75352
CY2022Q4 us-gaap Cash
Cash
477195
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
452625
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
500417
CY2023Q1 us-gaap Assets Current
AssetsCurrent
527977
CY2022Q4 us-gaap Assets Current
AssetsCurrent
977612
CY2023Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
328325574
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
325436230
CY2023Q1 us-gaap Assets
Assets
328853551
CY2022Q4 us-gaap Assets
Assets
326413842
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
254704
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
105642
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4661083
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3184482
CY2023Q1 gsrm Franchise Tax Payable
FranchiseTaxPayable
50000
CY2022Q4 gsrm Franchise Tax Payable
FranchiseTaxPayable
200050
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
1529043
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
890770
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6494830
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4380944
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
326646768
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
324245647
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4288838
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2213540
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-4288047
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2212749
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
328853551
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
326413842
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2075298
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
162637
CY2023Q1 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
50000
CY2022Q1 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
49813
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2125298
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-212450
CY2023Q1 gsrm Change In Value Of Investments Held In Trust Account
ChangeInValueOfInvestmentsHeldInTrustAccount
-3089394
CY2022Q1 gsrm Change In Value Of Investments Held In Trust Account
ChangeInValueOfInvestmentsHeldInTrustAccount
226760
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3089394
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-226760
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
964096
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-439210
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
638273
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
325823
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-439210
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2212749
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
2401121
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
325823
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-4288047
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
14035
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
12223750
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Mark To Market
AdjustmentsToAdditionalPaidInCapitalMarkToMarket
17710000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
135698
CY2022Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
27045604
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-439210
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2327273
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
325823
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-439210
CY2023Q1 gsrm Change In Value Of Investments Held In Trust Account
ChangeInValueOfInvestmentsHeldInTrustAccount
-3089394
CY2022Q1 gsrm Change In Value Of Investments Held In Trust Account
ChangeInValueOfInvestmentsHeldInTrustAccount
226760
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-47792
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
923011
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
149062
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8215
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1476601
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-10000
CY2023Q1 gsrm Increase Decrease In Franchise Tax Payable
IncreaseDecreaseInFranchiseTaxPayable
-150050
CY2022Q1 gsrm Increase Decrease In Franchise Tax Payable
IncreaseDecreaseInFranchiseTaxPayable
49145
CY2023Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
638273
CY2022Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
0
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-601893
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1088101
CY2023Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0
CY2022Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
320993750
CY2023Q1 gsrm Withdrawal Of Cash From Trust Account For Tax Payments
WithdrawalOfCashFromTrustAccountForTaxPayments
200050
CY2022Q1 gsrm Withdrawal Of Cash From Trust Account For Tax Payments
WithdrawalOfCashFromTrustAccountForTaxPayments
0
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
200050
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-320993750
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
CY2022Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
161543
CY2023Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0
CY2022Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
241543
CY2023Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
CY2022Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
316250000
CY2023Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0
CY2022Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
12223750
CY2023Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
CY2022Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4597351
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
323796399
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-401843
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1714548
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
477195
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
44739
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75352
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1759287
CY2023Q1 gsrm Offering Costs Included In Accrued Expenses
OfferingCostsIncludedInAccruedExpenses
0
CY2022Q1 gsrm Offering Costs Included In Accrued Expenses
OfferingCostsIncludedInAccruedExpenses
70000
CY2023Q1 gsrm Reversal Of Accrued Offering Costs
ReversalOfAccruedOfferingCosts
0
CY2022Q1 gsrm Reversal Of Accrued Offering Costs
ReversalOfAccruedOfferingCosts
-290000
CY2023Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2021-10-14
CY2023Q1 gsrm Threshold Minimum Aggregate Fair Market Value As Percentage Of Net Assets Held In Trust Account
ThresholdMinimumAggregateFairMarketValueAsPercentageOfNetAssetsHeldInTrustAccount
0.80
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
5000001
CY2023Q1 gsrm Threshold Percentage Of Public Shares Subject To Redemption Without Company Prior Written Consent
ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent
0.15
CY2023Q1 gsrm Percentage Of Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination
PercentageOfObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
1
CY2023Q1 gsrm Months To Complete Acquisition
MonthsToCompleteAcquisition
P15M
CY2023Q1 gsrm Maximum Period To Complete Acquisitions
MaximumPeriodToCompleteAcquisitions
P17M
CY2023Q1 gsrm Dissolution Expenses
DissolutionExpenses
100000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
75000
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001901799
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
GSR II Meteora Acquisition Corp.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity File Number
EntityFileNumber
001-41305
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-3203989
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
418 Broadway, Suite N
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Albany
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
12207
CY2023Q1 gsrm Working Capital Deficit
WorkingCapitalDeficit
6000000
CY2023Q1 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
1600000
CY2023Q1 gsrm Estimated Business Combination Date
EstimatedBusinessCombinationDate
2023-06-01
CY2023Q1 gsrm Estimated Business Combination Date
EstimatedBusinessCombinationDate
2023-06-01
CY2022Q3 gsrm Percentage Of Federal Excise Tax On Stock Buy Back
PercentageOfFederalExciseTaxOnStockBuyBack
0.01
CY2022Q3 gsrm Effective Date For Levy Of Federal Excise Tax On Stock Buy Back
EffectiveDateForLevyOfFederalExciseTaxOnStockBuyBack
2023-01-01
CY2022Q1 gsrm Per Unit Amount Of Marketing Fees May Be Paid At Sole Discretion Of Entity To Third Party Advisors Not Participated In Ipo That Assist In Consummate Business Combination
PerUnitAmountOfMarketingFeesMayBePaidAtSoleDiscretionOfEntityToThirdPartyAdvisorsNotParticipatedInIpoThatAssistInConsummateBusinessCombination
0.00105
CY2022Q1 gsrm Value Of Marketing Fees May Be Paid At Sole Discretion Of Entity To Third Party Advisors Not Participated In Ipo That Assist In Consummate Business Combination
ValueOfMarketingFeesMayBePaidAtSoleDiscretionOfEntityToThirdPartyAdvisorsNotParticipatedInIpoThatAssistInConsummateBusinessCombination
3300000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of income and expenses during the reporting periods. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </div>
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. As of March 31, 2023 and December 31, 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </div>
CY2023Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2023Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2023Q1 gsrm Restricted Investments Term
RestrictedInvestmentsTerm
P185D
CY2023Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1976562
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
325823
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-439210
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-2401121
CY2022Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-27045604
CY2023Q1 gsrm Net Income Loss Including Accretion Of Temporary Equity To Redemption Value
NetIncomeLossIncludingAccretionOfTemporaryEquityToRedemptionValue
-2075298
CY2022Q1 gsrm Net Income Loss Including Accretion Of Temporary Equity To Redemption Value
NetIncomeLossIncludingAccretionOfTemporaryEquityToRedemptionValue
-27484814
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 gsrm Percentage Of Total Number Of Shares Issued In The Initial Public Offering
PercentageOfTotalNumberOfSharesIssuedInTheInitialPublicOffering
0.20
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1976562
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1976562
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2023Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0
CY2022Q1 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
199998
CY2023Q1 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
66666
CY2023Q1 us-gaap Shares Issued
SharesIssued
0
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0
CY2023Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0

Files In Submission

Name View Source Status
0001193125-23-136197-index-headers.html Edgar Link pending
0001193125-23-136197-index.html Edgar Link pending
0001193125-23-136197.txt Edgar Link pending
0001193125-23-136197-xbrl.zip Edgar Link pending
d432921d10q.htm Edgar Link pending
d432921dex311.htm Edgar Link pending
d432921dex312.htm Edgar Link pending
d432921dex321.htm Edgar Link pending
d432921dex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gsrm-20230331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
gsrm-20230331_def.xml Edgar Link unprocessable
gsrm-20230331_lab.xml Edgar Link unprocessable
gsrm-20230331_pre.xml Edgar Link unprocessable
d432921d10q_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gsrm-20230331_cal.xml Edgar Link unprocessable